Literature DB >> 15345767

The independent living scales as a measure of functional outcome for schizophrenia.

Nadine Revheim1, Alice Medalia.   

Abstract

The Independent Living Scales (ILS) measures cognitive skills required for independent living and is intended to provide guidelines for appropriate supervision requirements for persons in residential placement. To assess the validity of the ILS among persons with schizophrenia, the instrument was administered to 162 individuals with schizophrenia who were living in three gradations of care: maximum supervision, moderate supervision, and minimal supervision. Scores on the ILS differed significantly across the three levels of care, whereas scores on the Global Assessment of Functioning (GAF) that were provided by clinicians discriminated only two levels of care. The ILS can be used among patients with schizophrenia to measure cognition as it affects functional outcome.

Entities:  

Mesh:

Year:  2004        PMID: 15345767     DOI: 10.1176/appi.ps.55.9.1052

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  23 in total

1.  A video ethnography approach for linking naturalistic behaviors to research constructs of neurocognition in schizophrenia.

Authors:  Elizabeth Bromley; Gail Fox Adams; John S Brekke
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

2.  A new dimension of sensory dysfunction: stereopsis deficits in schizophrenia.

Authors:  Isaac Schechter; Pamela D Butler; Maria Jalbrzikowski; Roey Pasternak; Alice M Saperstein; Daniel C Javitt
Journal:  Biol Psychiatry       Date:  2006-08-30       Impact factor: 13.382

Review 3.  Measurement of functional capacity: a new approach to understanding functional differences and real-world behavioral adaptation in those with mental illness.

Authors:  Thomas L Patterson; Brent T Mausbach
Journal:  Annu Rev Clin Psychol       Date:  2010       Impact factor: 18.561

Review 4.  A review of instruments for measuring functional recovery in those diagnosed with psychosis.

Authors:  Brent T Mausbach; Raeanne Moore; Christopher Bowie; Veronica Cardenas; Thomas L Patterson
Journal:  Schizophr Bull       Date:  2008-11-20       Impact factor: 9.306

Review 5.  Dependence as a unifying construct in defining Alzheimer's disease severity.

Authors:  Trent McLaughlin; Howard Feldman; Howard Fillit; Mary Sano; Frederick Schmitt; Paul Aisen; Christopher Leibman; Lisa Mucha; J Michael Ryan; Sean D Sullivan; D Eldon Spackman; Peter J Neumann; Joshua Cohen; Yaakov Stern
Journal:  Alzheimers Dement       Date:  2010-11       Impact factor: 21.566

6.  Auditory emotion recognition impairments in schizophrenia: relationship to acoustic features and cognition.

Authors:  Rinat Gold; Pamela Butler; Nadine Revheim; David I Leitman; John A Hansen; Ruben C Gur; Joshua T Kantrowitz; Petri Laukka; Patrik N Juslin; Gail S Silipo; Daniel C Javitt
Journal:  Am J Psychiatry       Date:  2012-04       Impact factor: 18.112

Review 7.  [Expression, identification and experience of emotions in mental diseases. An overview].

Authors:  K Wolf; R Maß; M Lambert; K Wiedemann; D Naber
Journal:  Nervenarzt       Date:  2014-03       Impact factor: 1.214

8.  Reading impairment and visual processing deficits in schizophrenia.

Authors:  Nadine Revheim; Pamela D Butler; Isaac Schechter; Maria Jalbrzikowski; Gail Silipo; Daniel C Javitt
Journal:  Schizophr Res       Date:  2006-08-04       Impact factor: 4.939

9.  The 5% difference: early sensory processing predicts sarcasm perception in schizophrenia and schizo-affective disorder.

Authors:  J T Kantrowitz; M J Hoptman; D I Leitman; G Silipo; D C Javitt
Journal:  Psychol Med       Date:  2013-04-24       Impact factor: 7.723

10.  Mental state decoding v. mental state reasoning as a mediator between cognitive and social function in psychosis.

Authors:  Nicola McGlade; Caragh Behan; Judy Hayden; Therese O'Donoghue; Rosie Peel; Farhan Haq; Michael Gill; Aiden Corvin; Eadbhard O'Callaghan; Gary Donohoe
Journal:  Br J Psychiatry       Date:  2008-07       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.